Effect of thyroid hormone on bone and mineral metabolism in rat: Evaluation by biochemical markers

Endocrine Research

Volumn 23, Issue 3, 1997, Pages 167-180

  Ishihara, C ^a   Kushida, K ^a   Takahashi, M ^a   Koyama, S ^a   Kawana, K ^a   Atsumi, K ^a   Inoue, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; LIOTHYRONINE; OSTEOCALCIN; PYRIDINOLINE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; CORTICAL BONE; FEMALE; MINERAL METABOLISM; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RAT; TRABECULAR BONE;

EID: 0030984178     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.3109/07435809709031851     Document Type: Article

References (28)

1. Mosekilde L, Eriksen EF, Charles P. 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35-63
2. Ohishi T, Takahashi M, Kushida K, Horiuchi K, Ishigaki S, Inoue T. 1992 Quantitative analyses of urinary pyridinoline and deoxypyridonoline excretion patient with hyperthyroidism. Endocrine Res 18:281-290
3. Ohishi T, Kushida K, Takahashi M, Kawana K, Yagi K, Kawakami K, Horiuchi K, Inoue T. 1994 Urinary bone resorption markers in patients with metabolic bone disorders. Bone 15:15-20
4. Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A, Robins SP. 1991 Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J.Clin.Endoclinol.Metab 72:1189-1194
5. Faber J, Perrild H, Johansen J S. 1991 Serum bone gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. Horm.metab.Res. 23:135-138
6. Barbara P. Lukert, Jan C. Higgins, Mary M. Stoskopf. 1986 Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62:1056-1058
7. Diamond T, Nery L, Hales I. 1991 A therapeutic dilemma:Suppressive doses of thyroxine significantly reduced bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184-1188
8. Garnero P, Vassy V, Bertholin A, Riou J.P, Delmas P.D. 1994 Markers of bone turnover in hyperthyroidism and the effects of treatment. J Clin Endocrinol Metab 78:955-959
9. Ongphiphadhanakul B, Alex S, Braverman L.E, Baran D.T. 1992 Excessive 1-thyroxine therapy decreases femoral bone mineral densities in the male rat: Effect of hypogonadism and calcitonin. J Bone Miner Res 7:1227-1231
10. Yamamoto M, Markatos A, Seedor J. G, Masarachia P, Gentile M, Rodan G. A, Balena R. 1993 The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats. Calcif Tissue Int 53:278-282
11. Rosen H.N, Sullivan E.K, Middlebrooks V.L, et al 1993 Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats. J Bone Miner Res 8:1255-1261
12. Fujimoto D, Moriguchi T, Ishida T, Hayashi H. 1987 The structure of pyridinoline, collagen crosslink.Biochem.Biophys.Res.Commun 87:52-57
13. Ogawa T, Ono T, Tsuda M, Kawanishi Y. 1982 Anovel fluor in insoluble collagen: a crosslinking molecule in collagen molecule. Biochem.Biophys. Res.Commun 107:1252-1257
14. Eyre D.R 1987 Collagen cross-linking aminoacids. Methods Enzymol 144:115-139
15. Robins S.P, Black D, Paterson C.R, Reid D.M, Duncan A, Seibel M.J. 1991 Evaluation of urinary hydroxypyridinium crosslink measurement as resorption markers in metabolic bone disease. Eur J Clin Invest 21:310-315
16. Anon. 1992 Pyridinium cross-links as markers of bone resorption (editorial). Lancet 340:278-279
17. Epstein S. 1988 Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev 9:437-49
18. Ohta T, Azuma Y, Kiyoki M, Eguchi H, Arita M, Hosoda K, Tsukamoto Y, Makamura T. 1996 Measurement of intact rat osteocalcin in osteoblast (ROS17/2.8) cells in ovariectomized rats with a sandwich enzyme immunoassay. Calcif Tissue Int 59:283-290
19. Takahashi M, Ohishi T, Aoshima H, Kushida K, Inoue T, Horiuchi K. 1993 Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J Liq Chromatogr 16:1355
20. Yamauchi H, Kushida K, Yamazaki K, Inoue T. 1995 Assessment of spine bone mineral density in ovariectomized rats using DXA. J Bone Miner Res 10:1033-1039
21. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. 1990 Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 33:143-153
22. Adlin EV, Maurer AH, Marks AD, Channick BJ. 1991 Bone mineral density in postmenopausal women treated with L-thyroxine. Am J Med 90:360-366
23. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. 1990 Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 113:265-269
24. Taelam P, Kaufman JM, Janssens X, vandecauter H, Vermeulen A. 1990 Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goiter treated with thyroid hormone. Clin Endocrinol (Oxf) 33:107-117
25. Paul TL, Kerrigan J, Kelly AM, Braverman LE, Baran DT. 1988 Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 259:3137-3141
26. Eriksen EF, Mosekilde L, Meisen F. 1985 Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6:421-428
27. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. 1993 Evaluation of bone turnover in typel osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 3:255-260
28. Kushida K, Takahashi M, Kawana K, Inoue T. 1995 Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab 80:2447-2450